Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06309719 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Hyaluronic Acid and Polynucleotides for Supra-bony Defects

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. 2 versions Re-verified since Jun 6, 2025, no change to tracked fieldsv5-v6
  2. Start date changed from estimate of Nov 2024 to Oct 21, 2024v4
  3. Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
    • Primary completion date: Sep 2025 to Dec 2026
    • Study completion date: Nov 2025 to Dec 2026
    • Start date: Oct 2024 to Nov 2024
    • Site details revised at 2 of 2 sites
  4. Start date: May 2024 to Oct 2024v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this pilot study is to describe the early wound healing molecular events and the vascularization pattern associated with the treatment of supra-bony defects with access flap alone or in association with a combined formulation of hyaluronic acid and polydeoxyribonucleotides gel.
Trial Details
NCT Number NCT06309719
Lead Sponsor Queen Mary University of London
Collaborators: Geistlich Pharma AG
Conditions
(from sponsor)		 Periodontal Diseases, Wound Heal, Periodontal Inflammation, Periodontal Pocket, Periodontal Attachment Loss
Related terms Periodontal Attachment Loss, Periodontal Diseases, Periodontal Pocket
Enrollment 24 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov